ID   INT.Ov2
AC   CVCL_DF87
SY   INTOV2
DR   cancercelllines; CVCL_DF87
DR   GEO; GSM313674
DR   Progenetix; CVCL_DF87
DR   Wikidata; Q54897818
RX   PubMed=9334822;
CC   HLA typing: A*01,02; B*35,49; C*04,06 (PubMed=9334822).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 7
//
RX   PubMed=9334822; DOI=10.1002/(SICI)1097-0215(19970926)73:1<143::AID-IJC22>3.0.CO;2-G;
RA   Ramakrishna V., Negri D.R.M., Brusic V., Fontanelli R., Canevari S.,
RA   Bolis G., Castelli C., Parmiani G.;
RT   "Generation and phenotypic characterization of new human ovarian
RT   cancer cell lines with the identification of antigens potentially
RT   recognizable by HLA-restricted cytotoxic T cells.";
RL   Int. J. Cancer 73:143-150(1997).
//